Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021

SELL
$17.54 - $25.43 $8.09 Million - $11.7 Million
-460,970 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$18.81 - $26.42 $1.87 Million - $2.62 Million
99,171 Added 27.41%
460,970 $8.89 Million
Q2 2020

Aug 12, 2020

BUY
$16.5 - $29.7 $913,671 - $1.64 Million
55,374 Added 18.07%
361,799 $9.45 Million
Q1 2020

May 12, 2020

BUY
$13.68 - $34.6 $4.19 Million - $10.6 Million
306,425 New
306,425 $5.47 Million

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $373M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.